Here's a recap of the week’s most important stories.

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

We recently compiled a list of the 8 Good Stocks To Buy Right Now. In this article, we are going to take a look at where ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to be looking for bargains all the more intently. On average, the ...

Pfizer, this name was all around the globe when the COVID-19 pandemic, as the American pharma giant was one of the first ...

The drug, Hympavzi, is given under the skin through an auto-injector pen to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older ...

Merck's P/S multiple is roughly 4, and its P/FCF is 21. That makes its valuation a bit pricier than Pfizer's per dollar of revenue, but significantly cheaper per dollar of free cash flow. In other ...